MAPT and Alzheimer disease: However, while the tau protein hyperphosphorylation hypothesis is well established, and targeting tau over-phosphorylation has emerged as a promising therapeutic strategy for AD, the relationship between tau pathology and other hallmarks of AD, such as Aβ accumulation and mitochondrial dysfunction, is still not fully understood.